Abstract
Alzheimer disease (AD) is a common neurodegenerative disease with pathological features of accumulated amyloid plaques, neurofibrillary tangles, and the significant inflammatory environment. These features modify the living microenvironment for nerve cells, causing the damage, dysfunction, and death. Progressive neuronal loss directly leads to cognitive decline in AD patients and is closely related to brain inflammation. Therefore, impairing inflammation via signaling pathways may facilitate either the prevention or delay of the degenerative process. Triptolide has been evidenced to possess potent anti-inflammatory effect. In this review, we elaborate on two signaling pathways (the NF-κB and Nrf2 signaling pathways) that are involved in the anti-inflammatory effect of triptolide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Al-Baradie RS, Pu S, Liu D, Zeinolabediny Y, Ferris G, Sanfeli C, Corpas R, Garcia-Lara E, Alsagaby SA, Alshehri BM, Abdel-Hadi AM, Ahmad F, Moatari P, Heidari N, Slevin M (2021) Monomeric C-Reactive protein localized in the cerebral tissue of damaged vascular brain regions is Associated with neuro-inflammation and Neurodegeneration-An immunohistochemical study. Front Immunol 12:644213. https://doi.org/10.3389/fimmu.2021.644213
Camporesi E, Lashley T, Gobom J, Lantero-Rodriguez J, Hansson O, Zetterberg H, Blennow K, Becker B (2021) Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers. Acta Neuropathol Commun 9(1):19. https://doi.org/10.1186/s40478-021-01119-4
Cao H, Zuo C, Gu Z, Huang Y, Yang Y, Zhu L, Jiang Y, Wang F (2022) High frequency repetitive transcranial magnetic stimulation alleviates cognitive deficits in 3xTg-AD mice by modulating the PI3K/Akt/GLT-1 axis. Redox Biol 54:102354. https://doi.org/10.1016/j.redox.2022.102354
Chen Q, Lei YQ, Liu JF, Wang ZC, Cao H (2021) Triptolide improves neurobehavioral functions, inflammation, and oxidative stress in rats under deep hypothermic circulatory arrest. Aging 13(2):3031–3044. https://doi.org/10.18632/aging.202460
Cheng S, LeBlanc KJ, Li L (2014) Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer’s disease. PLoS ONE 9(9):e108845. https://doi.org/10.1371/journal.pone.0108845
Cheng Y, Chen G, Wang L, Kong J, Pan J, Xi Y, Shen F, Huang Z (2018) Triptolide-induced mitochondrial damage dysregulates fatty acid metabolism in mouse sertoli cells. Toxicol Lett 292:136–150. https://doi.org/10.1016/j.toxlet.2018.04.035
Cui YQ, Wang Q, Zhang DM, Wang JY, Xiao B, Zheng Y, Wang XM (2016) Triptolide rescues spatial memory deficits and Amyloid-β aggregation accompanied by inhibition of inflammatory responses and MAPKs Activity in APP/PS1 transgenic mice. Curr Alzheimer Res 13(3):288–296. https://doi.org/10.2174/156720501303160217122803
Cui YQ, Zheng Y, Tan GL, Zhang DM, Wang JY, Wang XM (2019) (5R)-5-hydroxytriptolide inhibits the inflammatory cascade reaction in astrocytes. Neural Regen Res 14(5):913–920. https://doi.org/10.4103/1673-5374.249240
Deng X, Zeng T, Li J, Huang C, Yu M, Wang X, Tan L, Zhang M, Li A, Hu J (2019) Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury. Biomater Sci 7(12):5312–5323. https://doi.org/10.1039/c9bm01290g
Fang WY, Tseng YT, Lee TY, Fu YC, Chang WH, Lo WW, Lin CL, Lo YC (2021) Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway. Br J Pharmacol 178(15):2998–3016. https://doi.org/10.1111/bph.15472
Flores J, Fillion ML, LeBlanc AC (2022) Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice. Cell Death Dis 13(10):864. https://doi.org/10.1038/s41419-022-05290-x
Flores S, Chen CD, Su Y, Dincer A, Keefe SJ, McKay NS, Paulick AM, Perez-Carrillo GG, Wang L, Hornbeck RC, Goyal M, Vlassenko A, Schwarz S, Nickels ML, Wong DF, Tu Z, McConathy JE, Morris JC, Benzinger TLS, Gordon BA (2023) Investigating tau and amyloid Tracer Skull binding in studies of Alzheimer Disease. J Nucl Med 64(2):287–293. https://doi.org/10.2967/jnumed.122.263948
Ganz T, Fainstein N, Elad A, Lachish M, Goldfarb S, Einstein O, Ben-Hur T (2022) Microbial pathogens induce neurodegeneration in Alzheimer’s disease mice: protection by microglial regulation. J Neuroinflammation 19(1):5. https://doi.org/10.1186/s12974-021-02369-8
Hao M, Li X, Feng J, Pan N (2015) Triptolide protects against ischemic stroke in rats. Inflammation 38(4):1617–1623. https://doi.org/10.1007/s10753-015-0137-x
Hao QQ, Xu ZR, Nie H, Qiao FX, Sun MX, Liu YC, Wang HL, Qi ZQ, Xu CL, Liu Y (2023) Triptolide exposure induces oxidative stress and decreases oocyte quality in mouse. Toxicon 221:106964. https://doi.org/10.1016/j.toxicon.2022.106964
Hasnat M, Yuan Z, Naveed M, Khan A, Raza F, Xu D, Ullah A, Sun L, Zhang L, Jiang Z (2019) Drp1-associated mitochondrial dysfunction and mitochondrial autophagy: a novel mechanism in triptolide-induced hepatotoxicity. Cell Biol Toxicol 35(3):267–280. https://doi.org/10.1007/s10565-018-9447-8
Hasnat M, Yuan Z, Ullah A, Naveed M, Raza F, Baig MMFA, Khan A, Xu D, Su Y, Sun L, Zhang L, Jiang Z (2020) Mitochondria-dependent apoptosis in triptolide-induced hepatotoxicity is associated with the Drp1 activation. Toxicol Mech Methods 30(2):124–133. https://doi.org/10.1080/15376516.2019.1669247
Jia L, Nie XQ, Ji HM, Yuan ZX, Li RS, Multiple-Coated PLGA (2021) Nanoparticles loading Triptolide Attenuate Injury of a Cellular Model of Alzheimer’s Disease. Biomed Res Int 2021:8825640. https://doi.org/10.1155/2021/8825640
Jiang W, Chen M, Xiao C, Yang W, Qin Q, Tan Q, Liang Z, Liao X, Mao A, Wei C (2019) Triptolide suppresses growth of breast Cancer by targeting HMGB1 in Vitro and in vivo. Biol Pharm Bull 42(6):892–899. https://doi.org/10.1248/bpb.b18-00818
Jiao J, Xue B, Zhang L, Gong Y, Li K, Wang H, Jing L, Xie J, Wang X (2008) Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia. J Neuroimmunol 205(1–2):32–36. https://doi.org/10.1016/j.jneuroim.2008.08.006
Kim J, Um H, Kim NH, Kim D (2023) Potential Alzheimer’s disease therapeutic nano-platform: Discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles. Bioact Mater 24:497–506. https://doi.org/10.1016/j.bioactmat.2023.01.006
Kivisäkk P, Carlyle BC, Sweeney T, Quinn JP, Ramirez CE, Trombetta BA, Mendes M, Brock M, Rubel C, Czerkowicz J, Graham D, Arnold SE (2022) Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease. Alzheimers Res Ther 14(1):58. https://doi.org/10.1186/s13195-022-01002-x
Leyder E, Suresh P, Jun R, Overbey K, Banerjee T, Melnikova T, Savonenko A (2023) Depression-related phenotypes at early stages of Aβ and tau accumulation in inducible Alzheimer’s disease mouse model: Task-oriented and concept-driven interpretations. Behav Brain Res 438:114187. https://doi.org/10.1016/j.bbr.2022.114187
Li JM, Zhang Y, Tang L, Chen YH, Gao Q, Bao MH, Xiang J, Lei DL (2016) Effects of triptolide on hippocampal microglial cells and astrocytes in the APP/PS1 double transgenic mouse model of Alzheimer’s disease. Neural Regen Res 11(9):1492–1498. https://doi.org/10.4103/1673-5374.191224
Li P, Yang X, Yang Y, He H, Chou CK, Chen F, Pan H, Liu L, Cai L, Ma Y, Chen X (2020) Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice. J Control Release 319:87–103. https://doi.org/10.1016/j.jconrel.2019.12.025
Li L, Li Y, He B, Li H, Ji H, Wang Y, Zhu Z, Hu Y, Zhou Y, Yang T, Sun C, Yuan Y, Wang Y (2021) HSF1 is involved in suppressing A1 phenotype conversion of astrocytes following spinal cord injury in rats. J Neuroinflammation 18(1):205. https://doi.org/10.1186/s12974-021-02271-3
Liu M, Shi Z, Yin Y, Wang Y, Mu N, Li C, Ma H, Wang Q (2021a) Particulate matter 2.5 triggers airway inflammation and bronchial hyperresponsiveness in mice by activating the SIRT2-p65 pathway. Front Med 15(5):750–766. https://doi.org/10.1007/s11684-021-0839-4
Liu X, Hu C, Li H, Wu L, Xiong Y, Tang X, Deng S (2021b) Metabolic profiling of fatty acids in Tripterygium wilfordii multiglucoside- and triptolide-induced liver-injured rats. Open Life Sci 16(1):184–197. https://doi.org/10.1515/biol-2021-0016
Lu X, Yang B, Yu H, Hu X, Nie J, Wan B, Zhang M, Lü C (2019) Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice. Pharm Biol 57(1):453–459. https://doi.org/10.1080/13880209.2019.1629463
Lv L, Chang Y, Li Y, Chen H, Yao J, Xie Y, Liang X, Yang X, Zhang M, Liu G (2021) Triptolide induces Leydig Cell apoptosis by disrupting mitochondrial Dynamics in rats. Front Pharmacol 12:616803. https://doi.org/10.3389/fphar.2021.616803
Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, Mak E, Nicastro N, Bevan-Jones WR, Su L, Hong YT, Fryer TD, Aigbirhio FI, O’Brien JT, Rowe JB (2020) Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease. Brain 143(5):1588–1602. https://doi.org/10.1093/brain/awaa088
Mao R, Xu S, Sun G et al (2023) Triptolide injection reduces Alzheimer’s disease-like pathology in mice. Synapse 77(3):e22261. https://doi.org/10.1002/syn.22261
Merighi S, Nigro M, Travagli A, Gessi S (2022) Microglia and Alzheimer’s Disease. Int J Mol Sci 23(21):12990. https://doi.org/10.3390/ijms232112990
Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, Tousseyn T, De Strooper B, Thal DR (2023) Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol 145(2):175–195. https://doi.org/10.1007/s00401-022-02528-y
Moore EE, Liu D, Li J, Schimmel SJ, Cambronero FE, Terry JG, Nair S, Pechman KR, Moore ME, Bell SP, Beckman JA, Gifford KA, Hohman TJ, Blennow K, Zetterberg H, Carr JJ, Jefferson AL (2021) Association of aortic stiffness with biomarkers of Neuroinflammation, synaptic dysfunction, and Neurodegeneration. Neurology 97(4):e329–e340. https://doi.org/10.1212/WNL.0000000000012257
Nie J, Zhou M, Lü C, Hu X, Wan B, Yang B, Li Y (2012) Effects of triptolide on the synaptophysin expression of hippocampal neurons in the AD cellular model. Int Immunopharmacol 13(2):175–180. https://doi.org/10.1016/j.intimp.2012.03.021
Ning C, Mo L, Chen X, Tu W, Wu J, Hou S, Xu J (2018) Triptolide derivatives as potential multifunctional anti-alzheimer agents: synthesis and structure-activity relationship studies. Bioorg Med Chem Lett 28(4):689–693. https://doi.org/10.1016/j.bmcl.2018.01.019
Nordengen K, Kirsebom BE, Henjum K, Selnes P, Gísladóttir B, Wettergreen M, Torsetnes SB, Grøntvedt GR, Waterloo KK, Aarsland D, Nilsson LNG, Fladby T (2019) Glial activation and inflammation along the Alzheimer’s disease continuum. J Neuroinflammation 16(1):46. https://doi.org/10.1186/s12974-019-1399-2
Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. NeuroReport 10(11):2411–2415. https://doi.org/10.1097/00001756-199908020-00035
Qu C, Li QP, Su ZR, Ip SP, Yuan QJ, Xie YL, Xu QQ, Yang W, Huang YF, Xian YF, Lin ZX (2021) Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer’s disease via inhibiting neuropathology and modulating gut microbiota. J Adv Res 35:231–243. https://doi.org/10.1016/j.jare.2021.03.012
Ronning KE, Karlen SJ, Burns ME (2022) Structural and functional distinctions of co-resident microglia and monocyte-derived macrophages after retinal degeneration. J Neuroinflammation 19(1):299. https://doi.org/10.1186/s12974-022-02652-2
Sanadgol N, Golab F, Mostafaie A, Mehdizadeh M, Khalseh R, Mahmoudi M, Abdollahi M, Vakilzadeh G, Taghizadeh G, Sharifzadeh M (2018) Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation and acceleration of intrinsic myelin repair. Toxicol Appl Pharmacol 342:86–98. https://doi.org/10.1016/j.taap.2018.01.023
Seo EJ, Dawood M, Hult AK, Olsson ML, Efferth T (2021) Network pharmacology of triptolide in cancer cells: implications for transcription factor binding. Invest New Drugs 39(6):1523–1537. https://doi.org/10.1007/s10637-021-01137-y
Shan QQ, Jiang XJ, Wang FY, Shu ZX, Gui SY (2019) Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide. Drug Deliv 26(1):490–498. https://doi.org/10.1080/10717544.2019.1602796
Shen Q, Wang J, Yuan Z, Jiang Z, Shu T, Xu D, He J, Zhang L, Huang X (2019) Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis. Int Immunopharmacol 77:105959. https://doi.org/10.1016/j.intimp.2019.105959. Erratum in: Int Immunopharmacol. 2020;80:106228
Shi J, Ren Y, Ma J, Luo X, Li J, Wu Y, Gu H, Fu C, Cao Z, Zhang J (2021) Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis. J Nanobiotechnol 19(1):188. https://doi.org/10.1186/s12951-021-00934-0
Sivandzade F, Prasad S, Bhalerao A, Cucullo L (2019) NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches. Redox Biol 21:101059. https://doi.org/10.1016/j.redox.2018.11.017
Tahmasebi F, Barati S (2023) The role of Microglial Depletion Approaches in Pathological Condition of CNS. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-023-01326-8
Uruno A, Matsumaru D, Ryoke R, Saito R, Kadoguchi S, Saigusa D, Saito T, Saido TC, Kawashima R, Yamamoto M (2020) Nrf2 suppresses oxidative stress and inflammation in App Knock-In Alzheimer’s Disease Model mice. Mol Cell Biol 40(6):e00467–e00419. https://doi.org/10.1128/MCB.00467-19
Varma VR, Desai RJ, Navakkode S, Wong LW, Anerillas C, Loeffler T, Schilcher I, Mahesri M, Chin K, Horton DB, Kim SC, Gerhard T, Segal JB, Schneeweiss S, Gorospe M, Sajikumar S, Thambisetty M (2022) Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01912-0
Wan B, Hu X, Nie J, Zhou M, Yang B, Li Y, Wen W, Lü C (2014) Effects of triptolide on degeneration of dendritic spines induced by Aβ1–40 injection in rat hippocampus. Neurol Sci 35(1):35–40. https://doi.org/10.1007/s10072-013-1463-0
Wan YS, You Y, Ding QY, Xu YX, Chen H, Wang RR, Huang YW, Chen Z, Hu WW, Jiang L (2022) Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice. Acta Pharmacol Sin 43(1):15–25. https://doi.org/10.1038/s41401-021-00637-0
Wang Y, Mei Y, Feng D, Xu L (2008) Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurosci Res 86(11):2441–2449. https://doi.org/10.1002/jnr.21683
Wang J, Shi ZQ, Xu X, Xin GZ, Chen J, Qi LW, Li P (2013) Triptolide inhibits amyloid-β production and protects neural cells by inhibiting CXCR2 activity. J Alzheimers Dis 33(1):217–229. https://doi.org/10.3233/JAD-2012-120841
Wang Q, Xiao B, Cui S, Song H, Qian Y, Dong L, An H, Cui Y, Zhang W, He Y, Zhang J, Yang J, Zhang F, Hu G, Gong X, Yan Z, Zheng Y, Wang X (2014a) Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD. Dis Model Mech 7(12):1385–1395. https://doi.org/10.1242/dmm.018218
Wang X, Zhang L, Duan W, Liu B, Gong P, Ding Y, Wu X (2014b) Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model. Mol Med Rep 10(1):447–452. https://doi.org/10.3892/mmr.2014.2191
Wang Y, Guo SH, Shang XJ, Yu LS, Zhu JW, Zhao A, Zhou YF, An GH, Zhang Q, Ma B (2018) Triptolide induces sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response. Acta Pharmacol Sin 39(2):311–327. https://doi.org/10.1038/aps.2017.95
Wang Y, Zhang S, Li Z, Zeng H, Xian H, Huang Y (2020) The effects of triptolide on the cellular activity of cryopreserved rat sciatic nerves and nerve regeneration after allotransplantation. Int J Neurosci 130(1):83–96. https://doi.org/10.1080/00207454.2019.1664512
Wang K, Hu H, Cui W, Zhang X, Tang Q, Liu N, Lan X, Pan C (2021) Palliative effects of metformin on testicular damage induced by triptolide in male rats. Ecotoxicol Environ Saf 222:112536. https://doi.org/10.1016/j.ecoenv.2021.112536
Wei C, Li P, Liu L, Zhang H, Zhao T, Chen Y (2023) Degradable poly(amino acid) vesicles modulate DNA-Induced inflammation after traumatic brain Injury. Biomacromolecules. https://doi.org/10.1021/acs.biomac.2c01334
Wen JT, Liu J, Wan L, Xin L, Guo JC, Sun YQ, Wang X, Wang J (2022) Triptolide inhibits cell growth and inflammatory response of fibroblast-like synoviocytes by modulating hsa-circ-0003353/microRNA-31-5p/CDK1 axis in rheumatoid arthritis. Int Immunopharmacol 106:108616. https://doi.org/10.1016/j.intimp.2022.108616
Xi C, Peng S, Wu Z, Zhou Q, Zhou J (2017) Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother 90:531–541. https://doi.org/10.1016/j.biopha.2017.04.003
Xu P, Li Z, Wang H, Zhang X, Yang Z (2015) Triptolide Inhibited cytotoxicity of differentiated PC12 cells Induced by Amyloid-Beta25-35 via the Autophagy Pathway. PLoS ONE 10(11):e0142719. https://doi.org/10.1371/journal.pone.0142719
Xu P, Wang H, Li Z, Yang Z (2016) Triptolide attenuated injury via inhibiting oxidative stress in Amyloid-Beta25-35-treated differentiated PC12 cells. Life Sci 145:19–26. https://doi.org/10.1016/j.lfs.2015.12.018
Xu X, Piao HN, Aosai F, Zeng XY, Cheng JH, Cui YX, Li J, Ma J, Piao HR, Jin X, Piao LX (2020) Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB pathways. Br J Pharmacol 177(22):5224–5245. https://doi.org/10.1111/bph.15261
Xu P, Wu Z, Peng Y, Gao J, Zheng F, Tan J, Xu J, Wang T (2022) Neuroprotection of triptolide against Amyloid-Beta1-42-induced toxicity via the Akt/mTOR/p70S6K-mediated Autophagy Pathway. An Acad Bras Cienc 94(2):e20210938. https://doi.org/10.1590/0001-3765202220210938
Yalikong A, Li XQ, Zhou PH, Qi ZP, Li B, Cai SL, Zhong YS (2021) A Triptolide loaded HER2-Targeted Nano-Drug Delivery System significantly suppressed the proliferation of HER2-Positive and BRAF mutant Colon cancer. Int J Nanomedicine 16:2323–2335. https://doi.org/10.2147/IJN.S287732
Yang H, Qian H, Liu B, Wu Y, Cheng Y, Zheng X, Li X, Yang G, He T, Li S, Shen F (2021) Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice. Biomed Pharmacother 139:111569. https://doi.org/10.1016/j.biopha.2021.111569
Yu D, Liu Y, Zhou Y, Ruiz-Rodado V, Larion M, Xu G, Yang C (2020) Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. Proc Natl Acad Sci U S A 117(18):9964–9972. https://doi.org/10.1073/pnas.1913633117
Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A (2023) Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Transl Neurodegener 12(1):4. https://doi.org/10.1186/s40035-023-00336-2
Zeng H, Zhu X, Tian Q, Yan Y, Zhang L, Yan M, Li R, Li X, Wang G, Ma J, Su Y, Zhang X, Ma L, Zhang Z, Wu X (2020) In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration. Drug Deliv 27(1):848–854. https://doi.org/10.1080/10717544.2020.1770370
Zhang YQ, Shen Y, Liao MM, Mao X, Mi GJ, You C, Guo QY, Li WJ, Wang XY, Lin N, Webster TJ (2019) Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine 15(1):86–97. https://doi.org/10.1016/j.nano.2018.09.002
Zhang J, Zhu M, Zhang S, Xie S, Gao Y, Wang Y (2020) Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension. Int Immunopharmacol 89(Pt A):107035. https://doi.org/10.1016/j.intimp.2020.107035
Zhang L, Yan M, Chen K, Tian Q, Song J, Zhang Z, Xie Z, Yuan Y, Jia Y, Zhu X, Zhang Z, Wu X, Zeng H (2020b) Novel Carboxylated Chitosan-Based Triptolide Conjugate for the treatment of rheumatoid arthritis. Pharmaceutics 12(3):202. https://doi.org/10.3390/pharmaceutics12030202
Zhang J, Song N, Liu Y, Guo J (2021) Platycodin D inhibits β-Amyloid-Induced inflammation and oxidative stress in BV-2 cells Via suppressing TLR4/NF-κB signaling pathway and activating Nrf2/HO-1 signaling pathway. Neurochem Res 46(3):638–647. https://doi.org/10.1007/s11064-020-03198-6
Zhang S, Xie S, Gao Y, Wang Y (2022) Triptolide alleviates oxidized LDL-Induced endothelial inflammation by attenuating the oxidative stress-mediated Nuclear Factor-Kappa B pathway. Curr Ther Res Clin Exp 97:100683. https://doi.org/10.1016/j.curtheres.2022.100683
Zhang H, Cao S, Xu Y, Sun X, Fei M, Jing Q, Xu X, Tang J, Niu B, Li C (2022a) Landscape of immune infiltration in entorhinal cortex of patients with Alzheimer’s disease. Front Pharmacol 13:941656. https://doi.org/10.3389/fphar.2022.941656
Zhu S, Wang X, Zheng Z, Zhao XE, Bai Y, Liu H (2020) Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer’s disease rats. J Pharm Biomed Anal 185:113263. https://doi.org/10.1016/j.jpba.2020.113263
Zou M, Nong C, Yu Z, Cai H, Jiang Z, Xue R, Huang X, Sun L, Zhang L, Wang X (2020) The role of invariant natural killer T cells and associated immunoregulatory factors in triptolide-induced cholestatic liver injury. Food Chem Toxicol 146:111777. https://doi.org/10.1016/j.fct.2020.111777
Acknowledgements
We thank Shaoxing University for infrastructure support.
Funding
None.
Author information
Authors and Affiliations
Contributions
All authors agreed to publish this article. XL designed the study. ZH, BOAB, YZ and XL prepared the first draft of the manuscript. ZH, YZ, BOAB and XL revised the manuscript. All authors approved the final article.
Corresponding author
Ethics declarations
Ethical statement
We declared that there were no ethical issues.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
All the authors have read and approved the final manuscript.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Zuoting He, Benson O.A. Botchway and Yong Zhang contributed equally to this work
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
He, Z., Botchway, B.O., Zhang, Y. et al. Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease. Metab Brain Dis 39, 173–182 (2024). https://doi.org/10.1007/s11011-023-01278-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01278-4